Expression of HOXD3 correlates with shorter survival in patients with invasive breast cancer

Clinical and Experimental Metastasis

Volumn 30, Issue 2, 2013, Pages 155-163

  Shaoqiang, Cheng ^a   Yue, Zhang ^a   Yang, Liu ^a   Hong, Zhao ^a   Lina, Zhen ^a   Da, Pang ^a   Qingyuan, Zhang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Hormone receptor negative; HOXD3; Integrin 3; Survival

Indexed keywords

BETA3 INTEGRIN; CELL PROTEIN; ESTROGEN RECEPTOR; HOXD3 PROTEIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; HOXD3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER SIZE; CANCER SURVIVAL; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; PROTEIN EXPRESSION; SURVIVAL TIME; BREAST TUMOR; CANCER GRADING; CANCER INVASION; CANCER STAGING; ENZYME IMMUNOASSAY; FOLLOW UP; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRIN BETA3; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84875058035     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9524-y     Document Type: Article

References (33)

1. Gehring WJ, Hiromi Y (1986) Homeotic genes and the homeobox. Annu Rev Genet 20:147-173
2. Scott MP (1992) Vertebrate homeobox gene nomenclature. Cell 71:551-553
3. Graham A, Papalopulu N, Krumlauf R (1989) The murine and Drosophila homeobox gene complexes have common features of organization and expression. Cell 57:367-378
4. McGinnis W, Krumlauf R (1992) Homeobox genes and axial patterning. Cell 68:283-302
5. Levine M, Hoey T (1988) Homeobox proteins as sequence-specific transcription factors. Cell 55:537-540
6. Ruddle FH et al (1994) Evolution of Hox genes. Annu Rev Genet 28:423-442
7. Mark M, Rijli FM, Chambon P (1997) Homeobox genes in embryogenesis and pathogenesis. Pediatr Res 42:421-429
8. Takahashi Y et al (2004) Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 293:144-153
9. Abate-Shen C (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2:777-785
10. Raman V et al (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405:974-978
11. Trivedi CM, Patel RC, Patel CV (2007) Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis 195:e50-e60
12. Trivedi CM, Patel RC, Patel CV (2008) Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-kappaB) and HOXA9. Gene 408:187-195
13. Wu X et al (2006) HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res 66:9527-9534
14. Condie BG, Capecchi MR (1993) Mice homozygous for a targeted disruption of Hoxd-3 (Hox-4.1) exhibit anterior transformations of the first and second cervical vertebrae, the atlas and the axis. Development 119:579-595
15. Manley NR, Capecchi MR (1998) Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands. Dev Biol 195:1-15
16. Hamada J et al (2001) Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer 93:516-525
17. Taniguchi Y, Komatsu N, Moriuchi T (1995) Overexpression of the HOX4A (HOXD3) homeobox gene in human erythroleukemia HEL cells results in altered adhesive properties. Blood 85:2786-2794
18. Haybittle JL et al (1982) A prognostic index in primary breast cancer. Br J Cancer 45:361-366
19. Kowalski PJ, Rubin MA, Kleer CG (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5:R217-R222
20. Huber GF et al (2011) Down regulation of E-cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC cancer 11(217):1-8
21. Kashiwagi S et al (2010) Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer 103:249-255
22. Frixen UH et al (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185
23. Vleminckx K et al (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119
24. Watabe M et al (1994) Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127:247-256
25. Mariotti A et al (2007) N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs 16:451-465
26. Cavallaro U (2004) N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Investig Drugs 5:1274-1278
27. Hazan RB et al (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779-790
28. Planaguma J et al (2011) Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma. Hum Pathol 42:57-67
29. Shen Q et al (2010) Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells. Mol Cancer Res 8:939-951
30. Takayama S et al (2005) The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res 25:79-83
31. Scatena M et al (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141:1083-1093
32. Matter ML, Ruoslahti E (2001) A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription. J Biol Chem 276:27757-27763
33. De S et al (2005) VEGF-integrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci USA 102:7589-7594